Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis

Neurology

Volumn 85, Issue 3, 2015, Pages 248-255

  Daams, Marita ^a   Steenwijk, Martijn D ^a   Wattjes, Mike P ^a   Geurts, Jeroen J G ^a   Uitdehaag, Bernard M J ^a   Tewarie, Prejaas K ^a   Balk, Lisanne J ^a   Pouwels, Petra J W ^a   Killestein, Joep ^a   Barkhof, Frederik ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BRAIN SIZE; BRAIN STEM; CERVICAL SPINAL CORD; CERVICAL SPINAL CORD INJURY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOTOR SYSTEM; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS WALKING SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PYRAMIDAL TRACT; WHOLE BODY MRI; AGED; MIDDLE AGED; MOTOR SKILLS DISORDERS; PREDICTIVE VALUE; PROSPECTIVE STUDY; TRENDS;

ADULT; AGED; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS DISORDERS; MULTIPLE SCLEROSIS; NEUROIMAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 84937696171     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001756     Document Type: Article

References (37)

1. Geurts JJG, Stys PK, Minagar A, Amor S, Zivadinov R. Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci 2009; 282: 12-20
2. Larocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient 2011; 4: 189-201
3. Motl RW. Physical activity and irreversible disability in multiple sclerosis. Exerc Sport Sci Rev 2010; 38: 186-191
4. Barkhof F. MRI in multiple sclerosis: correlation with Expanded Disability Status Scale (EDSS). Mult Scler 1999; 5: 283-286
5. Tovar-Moll F, Evangelou IE, Chiu AW, et al. Diffuse and focal corticospinal tract disease and its impact on patient disability in multiple sclerosis. J Neuroimaging 2014; 25: 200-206
6. Sbardella E, Petsas N, Tona F, et al. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. PLoS One 2013; 8: e63250
7. Wilson M, Tench CR, Morgan PS, Blumhardt LD. Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry 2003; 74: 203-207
8. Lin X, Tench CR, Morgan PS, Niepel G, Constantinescu CS. Importance sampling in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment. J Neurol Sci 2005; 237: 13-19
9. Onu M, Roceanu A, Sboto-Frankenstein U, et al. Diffusion abnormality maps in demyelinating disease: correlations with clinical scores. Eur J Radiol 2012; 81: e386-e391
10. Poloni G, Minagar A, Haacke EM, Zivadinov R. Recent developments in imaging of multiple sclerosis. Neurologist 2011; 17: 185-204
11. Lin F, Yu C, Jiang T, Li K, Chan P. Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol 2007; 28: 278-282
12. Pagani E, Filippi M, Rocca MA, Horsfield MA A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2005; 26: 258-265
13. Edwards SG, Gong QY, Liu C, et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 1999; 122: 291-301
14. Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999; 66: 323-330
15. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712
16. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302
17. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911
18. Steenwijk MD, Daams M, Pouwels PJ, et al. What explains gray matter atrophy in long-standing multiple sclerosis? Radiology 2014; 272: 832-842
19. Daams M, Weiler F, Steenwijk MD, et al. Mean upper cervical cord area (MUCCA) measurement in longstanding multiple sclerosis: relation to brain findings and clinical disability. Mult Scler 2014; 20: 1860-1865
20. Balk LJ, Steenwijk MD, Tewarie P, et al. Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; 86: 419-424
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452
22. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-250
23. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60: 31-36
24. Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp 2012; 33: 2802-2814
25. Battaglini M, Jenkinson M, De Stefano N. Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2012; 33: 2062-2071
26. Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CAM. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010; 32: 223-228
27. Steenwijk MD, Pouwels PJ, Daams M, et al. Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs). Neuroimage Clin 2013; 3: 462-469
28. Geurts JJG, Roosendaal SD, Calabrese M, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011; 76: 418-424
29. Hua K, Zhang J, Wakana S, et al. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage 2008; 39: 336-347
30. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis: I: segmentation and surface reconstruction. Neuroimage 1999; 9: 179-194
31. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis: II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999; 9: 195-207
32. Purves D, Augustine GJ, Fitzpatrick D, et al, editors. Neuroscience, 2nd ed. Sunderland, MA: Sinauer Associates; 2001
33. Reich DS, Smith SA, Zackowski KM, et al. Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage 2007; 38: 271-279
34. Spanò B, Cercignani M, Basile B, et al. Multiparametric MR investigation of the motor pyramidal system in patients with truly benign multiple sclerosis. Mult Scler 2010; 16: 178-188
35. Fisniku LK, Chard DT, Jackson JS, et al. Gray matter atrophy is related to long-Term disability in multiple sclerosis. Ann Neurol 2008; 64: 247-254
36. Damasceno A, Damasceno BP, Cendes F. The clinical impact of cerebellar grey matter pathology in multiple sclerosis. PLoS One 2014; 9: e96193
37. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67: 960-967